EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...
Also complicating matters last year was a dispute with Shanghai biotech Nuance Pharma over a licensing agreement for otenaproxesul in the Greater China region, which resulted in an order for ...
such as Bavarian Nordic’s agreement to progress a potential RSV vaccine developed by Nuance Pharma. Evolving regulatory landscape However, the developing commercial relationship between ...
This study is being conducted by Verona's partner in Greater China, Nuance Pharma. Results from the trial are expected in 2025. When we alerted readers to VRNA on May 17, 2024, it was trading at ...